Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Chambers

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 19, 2015
Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survivalHarry M Gallagher, Ghulam Sarwar, Tracy Tse, et al.
Respirology (Carlton, Vic.)|February 24, 2021
Radiological outcomes of whole lung lavage for artificial stone-associated silicosisDaniel C Chambers, Simon H Apte, David Deller, et al.
BMJ Open Respiratory Research|December 6, 2019
Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease-health care utilisation in the subsequent 2 yearsJames R Walsh, Jane Pegg, Stephanie T Yerkovich, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 28, 2023
Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature reviewChandima Divithotewala, Emma L Sweeney, Andrew Burke, et al.
Clinical Transplantation|July 3, 2013
Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strengthJames R Walsh, Daniel C Chambers, Rebecca J Davis, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2013
Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndromeDana L Willner, Philip Hugenholtz, Stephanie T Yerkovich, et al.
Frontiers in Cellular and Infection Microbiology|August 28, 2024
Cloaking antibodies are prevalent in <i>Burkholderia cepacia</i> complex infection and their removal restores serum killingAmy Pham, Kellynn K Y Tan, Emma L Ledger, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 28, 2021
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Barbara de Graaff, Tamera J Corte, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 6, 2021
Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodiesChandima Divithotawela, Amy Pham, Peter T Bell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 26, 2011
The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndromeBalarka Banerjee, Kak-Ming Ling, Erika N Sutanto, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 19, 2015
Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survivalHarry M Gallagher, Ghulam Sarwar, Tracy Tse, et al.
Respirology (Carlton, Vic.)|February 24, 2021
Radiological outcomes of whole lung lavage for artificial stone-associated silicosisDaniel C Chambers, Simon H Apte, David Deller, et al.
BMJ Open Respiratory Research|December 6, 2019
Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease-health care utilisation in the subsequent 2 yearsJames R Walsh, Jane Pegg, Stephanie T Yerkovich, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 28, 2023
Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature reviewChandima Divithotewala, Emma L Sweeney, Andrew Burke, et al.
Clinical Transplantation|July 3, 2013
Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strengthJames R Walsh, Daniel C Chambers, Rebecca J Davis, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2013
Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndromeDana L Willner, Philip Hugenholtz, Stephanie T Yerkovich, et al.
Frontiers in Cellular and Infection Microbiology|August 28, 2024
Cloaking antibodies are prevalent in <i>Burkholderia cepacia</i> complex infection and their removal restores serum killingAmy Pham, Kellynn K Y Tan, Emma L Ledger, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 28, 2021
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Barbara de Graaff, Tamera J Corte, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 6, 2021
Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodiesChandima Divithotawela, Amy Pham, Peter T Bell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 26, 2011
The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndromeBalarka Banerjee, Kak-Ming Ling, Erika N Sutanto, et al.
Pageof 13